Group sequential methods and software applications

American Statistician

Volumn 65, Issue 2, 2011, Pages 127-135

  Zhu, Li ^a   Ni, Liyun ^a   Yao, Bin ^a  

^a AMGEN INC   (United States)

Author keywords

Conditional power; Error spending function; Interim monitoring; Stopping boundary

Indexed keywords

EID: 79960950486     PISSN: 00031305     EISSN: None     Source Type: Journal    
DOI: 10.1198/tast.2011.10213     Document Type: Article

References (27)

1. Anderson, K. (2009), gsDesign: An R Package for Designing Group Sequential Clinical Trials, Version 2.0 Manual, available at http://cran.r-project.org/src/ contrib/gsDesign_2.4-01.tar.gz. [127]
2. Armitage, P. (1957), "Restricted Sequential Procedures," Biometrika, 44, 9-56. [127,129]
3. Armitage, P. (1975), Sequential Medical Trials, Oxford: Blackwell Scientific Publications. [127]
4. Armitage, P., McPherson, C. K., and Rowe, B. C. (1969), "Repeated Significance Tests on Accumulating Data," Journal of the Royal Statistical Society, Ser. A, 132, 232-244. [128]
5. Cytel Inc. (2010), EAST Advanced Clinical Trial Design, Simulation and Monitoring System, Version 5. Reference Manual, Cambridge, MA: Cytel Inc. [129]
6. Haybittle, J. L. (1971), "Repeated Assessment of Results in Clinical Trials of Cancer Treatment," The British Journal of Radiology, 44, 793-797. [128]
7. Hwang, I. K., Shih, W. J., and DeCani, J. S. (1990), "Group Sequential Designs Using a Family of Type I Error Probability Spending Functions," Statistics in Medicine, 9, 1439-1445. [128,130]
8. Jennison, C., and Turnbull, B. W. (1989), "Interim Analyses: The Repeated Confidence Interval Approach" (with discussion), Journal of the Royal Statistical Society, Ser. B, 51, 305-361. [128]
9. Jennison, C., and Turnbull, B. W. (2000), Group Sequential Methods With Applications to Clinical Trials, London: Chapman & Hall/CRC. [127-129]
10. Kim, K., and DeMets, D. L. (1987), "Confidence Intervals Following Group Sequential Test in Clinical Trials," Biometrics, 43, 857-864. [128]
11. Lachin, J. M., and Foulkes, M. A. (1986), "Evaluation of Sample Size and Power for Analysis of SurvivalWith Allowance for Nonuniform Patient Entry, Losses to Follow-Up, Noncompliance, and Stratification," Biometrics, 42, 507-519. [134]
12. Lan, K. K. G., and DeMets, D. L. (1983), "Discrete Sequential Boundaries for Clinical Trials," Biometrika, 70, 659-663. [127,128]
13. Lan, K. K. G., and Wittes, J. (1988), "The B-Value: A Tool for Monitoring Data," Biometrics, 44, 579-585. [128]
14. Liu, Q., and Anderson, K. (2008), "On Adaptive Extensions of Group Sequential Trials for Clinical Investigations," Journal of the American Statistical Association, 103, 1621-1630. [129]
15. MPS Research Unit (2000), PEST 4: OperatingManual, University of Reading, Reading, U.K. [127]
16. Muller, H.-H., and Schafer, H. (2001), "Adaptive Group Sequential Designs for Clinical Trials: Combining the Advantages of Adaptive and of Classical Group Sequential Approaches," Biometrics, 57, 886-891. [132]
17. O'Brien, P. C., and Fleming, T. R. (1979), "A Multiple Testing Procedure for Clinical Trials," Biometrics, 35, 549-556. [127,128]
18. Pampallona, S., Tsiatis, A. A., and Kim, K. (1995), "Spending Functions for Type I and Type II Error Probabilities of Group Sequential Trials," Technical report, Dept. of Biostatistics, Harvard School of Public Health, Boston. [131]
19. Pocock, S. J. (1977), "Group Sequential Methods in the Design and Analysis of Clinical Trials," Biometrika, 64, 191-199. [127,128]
20. Proschan, M. A., Lan, K. K. G., and Wittes, J. (2006), Statistical Monitoring of Clinical Trials-A Unified Approach, New York: Springer. [127,129]
21. Scharfstein, D. O., Tsiatis, A. A., and Robins, J. M. (1997), "Semiparametric Efficiency and Its Implication on the Design and Analysis of Group- Sequential Studies," Journal of the American Statistical Association, 92, 1342-1350. [128]
22. The CAPTURE Investigators (1997), "Randomised Placebo-Controlled Trial of Abciximab Before and During Coronary Intervention in Refractory Unstable Angina: The CAPTURE Study," Lancet, 349, 1429-1435. [127,129]
23. Tsiatis, A. A. (1982), "Repeated Significance Testing for a General Class of Statistics Used in Censored Survival Analysis," Journal of the American Statistical Association, 77, 855-861. [127]
24. Tsiatis, A. A., Rosner, G. L., and Mahta, C. R. (1984), "Exact Confidence Intervals Following a Group Sequential Test," Biometrics, 40, 797-803. [129]
25. Wald, A. (1947), Sequential Analysis, New York: Wiley. [127]
26. Whitehead, J. (1997), The Design and Analysis of Sequential Clinical Trials (revised 2nd ed.), Chichester: Wiley. [127]
27. Whitehead, J (2010), "Group Sequential Trials Revisited: Simple Implementation Using SAS," Statistical Methodsin Medical Research, to appear, doi:10.1177/0962280210379036. [127]